CSPIA
AVNS

Cary Street Partners Investment Advisory’s Avanos Medical AVNS Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-260
Closed -$2.92K – 693
2025
Q4 		$2.92K Sell
260
-46
-15% -$526 ﹤0.01% 654
2025
Q3 		$3.54K Buy
+306
New +$3.58K ﹤0.01% 574
2023
Q4 		– Sell
-86
Closed -$1.74K – 712
2023
Q3 		$1.74K Buy
+86
New +$1.95K ﹤0.01% 1679
2020
Q4 		– Sell
-68
Closed -$2K – 384
2020
Q3 		$2K Buy
+68
New +$2.17K ﹤0.01% 903

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Cary Street Partners Investment Advisory's AVNS Position: Q1 2026 in Review

Cary Street Partners Investment Advisory sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 260 shares — an estimated $2.92K sold.

Cary Street Partners Investment Advisory first reported a position in AVNS in Q3 2020 and held it in 4 quarters. The position peaked at $3.54K in Q3 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Cary Street Partners Investment Advisory reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 260 Avanos Medical shares in Q1 2026, an estimated $2.92K.
  • Cary Street Partners Investment Advisory first reported a position in Avanos Medical in Q3 2020 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Avanos Medical position peaked at $3.54K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q1 2026, filed 29 Apr 2026.